Table 4.
Long‐Term Clinical Outcome by BMI0–6months Trajectory
| Total (n=390) | Lower (n=31) | Middle (n=255) | Upper (n=99) | P value | |
|---|---|---|---|---|---|
| Severe Fontan failure | 36 (9) | 6 (17) | 24 (9) | 6 (6) | 0.17 |
| Deceased | 18 (6) | 6 (17) | 10 (3.92) | 2 (2) | <0.01 |
| Age deceased, y (median [IQR]) | 20 (10–26) | 16 (6–32) | 24.5 (10–26) | 17.5 (14–21) | 0.90 |
| Age at last follow‐up/censoring, y (median [IQR]) | 15 (8–16) | 13 (8–16) | 12 (8–16) | 13 (8–16) | 0.38 |
| Heart transplant | 8 (2) | 1 (3) | 6 (2) | 1 (1) | 0.69 |
| Takedown | 3 (1) | 1 (3) | 2 (1) | 0 | 0.26 |
| New York Heart Association III/IV | 16 (4) | 1 (3) | 12 (5) | 3 (3) | 0.85 |
| Ventricular failure | |||||
| None‐mild | 184 (91) | 22 (96) | 117 (89) | 45 (94) | 0.84 |
| Moderate | 16 (8) | 1 (4) | 12 (9) | 3 (6) | |
| Severe | 3 (1) | 0 | 3 (2) | 0 | |
| Valvular regurgitation | |||||
| None‐mild | 164 (81) | 19 (83) | 106 (80) | 39 (81) | 0.87 |
| Moderate | 31 (15) | 4 (17) | 19 (14) | 8 (17) | |
| Severe | 8 (4) | 0 | 7 (5) | 1 (2) | |
| Venous thromboembolism | 58 (15) | 6 (17) | 35 (13) | 17 (17) | 0.69 |
Values are given as No. (%) unless otherwise indicated. P value X2(2, N=390) indicates comparison between pediatric BMI0–6months trajectory groups. BMI indicates body mass index.